COLUMBUS, Ohio—Dr. E. Antonio Chiocca (43065), chair of the department of neurological surgery at The Ohio State University Medical Center, was elected to the board of directors of the Society for Neuro-Oncology. Chiocca will represent the neurosurgical subspecialty from 2008-2011 during bi-monthly teleconferences.
Chiocca and his team of researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute are investigating the use of biologic therapies and gene delivery methods to treat brain tumors and other central nervous system disorders.
The Society for Neuro-Oncology was formed in 1995 and focuses on the advancement of neuro-oncology through education and research. With 1,100 members worldwide, the society takes a multidisciplinary approach, bringing together doctors and researchers from clinical, translational and laboratory perspectives.
Chiocca, who holds the Dardinger Family Endowed Chair in Oncological Neurosurgery, recently received a $5.5 million grant over five years from the National Institutes of Health to develop a more potent oncolytic virus as a treatment for brain cancer.
The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute is one of only 40 NCI-designated Comprehensive Cancer Centers in the United States and the only freestanding cancer hospital in the Midwest. Ranked among the top 20 cancer hospitals in the nation, The James is the 172-bed adult patient-care component of the cancer program at The Ohio State University.# # #
Medical Center Communications